Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis

Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis

Show other versions (1)

Respiratory infection is very common in patients suffering from cystic fibrosis (CF). However, the antimicrobial resistance rate of isolates from CF patients is not often documented. In this study, 279 respiratory specimens of 146 patients were prospectively collected from July to December 2006. Mic...

Full description

Bibliographic Details
Main Authors:	Vilma Almeida Paixão, Tânia Fraga Barros, Clélia Maria C Mota, Tamy Fagundes Moreira, Maria Angélica Santana, Joice Neves Reis
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	cystic fibrosis antimicrobial resistance Pseudomonas aeruginosa Staphylococcus aureus
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000400016&lng=en&tlng=en

Similar Items

Escore tomográfico em pacientes com fibrose cística colonizados por Pseudomonas aeruginosa ou Staphylococcus aureus High-resolution computed tomography scores in cystic fibrosis patients colonized with Pseudomonas aeruginosa or Staphylococcus aureus
by: Tania Wrobel Folescu, et al.
Published: (2012-02-01)

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates
by: Valerio eIebba, et al.
Published: (2014-06-01)

Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis
by: Lalitha Biswas, et al.
Published: (2022-01-01)

The Role of HLA-DRB1 Alleles in Pulmonary Cystic Fibrosis
by: Alireza Asef, et al.
Published: (2022-04-01)

Impact of Coexistence Phenotype Between Staphylococcus aureus and Pseudomonas aeruginosa Isolates on Clinical Outcomes Among Cystic Fibrosis Patients
by: Paul Briaud, et al.
Published: (2020-06-01)

Bicarbonate Inhibits Bacterial Growth and Biofilm Formation of Prevalent Cystic Fibrosis Pathogens
by: Orsolya Dobay, et al.
Published: (2018-09-01)

Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis
by: Cristina Cigana, et al.
Published: (2023-02-01)

Unveiling Co-Infection in Cystic Fibrosis Airways: Transcriptomic Analysis of Pseudomonas aeruginosa and Staphylococcus aureus Dual-Species Biofilms
by: Andreia Patrícia Magalhães, et al.
Published: (2022-07-01)

A Continuous-Flow Model for in vitro Cultivation of Mixed Microbial Populations Associated With Cystic Fibrosis Airway Infections
by: Thomas James O’Brien, et al.
Published: (2019-11-01)

Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis
by: Anna-Maria Dittrich, et al.
Published: (2024-02-01)

Genotypic and Phenotypic Diversity of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
by: Eryn E. Bernardy, et al.
Published: (2020-06-01)

Antibiotic Susceptibility of Pseudomonas Aeruginosa Isolated from Cystic Fibrosis Patients
by: Soltan Dallal, MM, et al.
Published: (2015-01-01)

Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis
by: Vilma Almeida Paixão, et al.
Published: (2010-07-01)

Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis
by: Catherine R. Armbruster, et al.
Published: (2022-10-01)

LOWER RESPIRATORY TRACT MICROBIOTA AND ITS SENSITIVITY TO ANTIBACTERIAL AGENTS IN CHILDREN WITH CYSTIC FIBROSIS
by: Яков Яковлевич Яковлев, et al.
Published: (2022-08-01)

Study of the effect of trebenides received from green tea Khmer and bacterial races
by: Meshal Alenezi, et al.
Published: (2007-06-01)

Polymyxin B and ethylenediaminetetraacetic acid act synergistically against Pseudomonas aeruginosa and Staphylococcus aureus
by: Samuel J. M. Hale, et al.
Published: (2024-02-01)

Evolution of Bacterial “Frenemies”
by: Sophie E. Darch, et al.
Published: (2017-07-01)

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
by: Carla M. P. Ribeiro, et al.
Published: (2023-03-01)

DECELERATION OF BACTERIAL GROWTH IN STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA CULTURES IN THE PRESENCE OF COPPER AND ZINC CATIONS
by: S. B Cheknev, et al.
Published: (2015-04-01)

Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis
by: Shaghayegh Tavakoli Tabazavareh, et al.
Published: (2016-05-01)

Detection of Morphotyping Characteristics Identification Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis
by: Hossein Fazeli, et al.
Published: (2012-03-01)

THE PREVALENCE OF PSEUDOMONAS AERUGINOSA STRAINS IN INFANTS WITH CYSTIC FIBROSIS WITHIN A HOSPITAL IN NORTH EASTER OF ROMANIA
by: Oana Alexandra Ciocan, et al.
Published: (2016-11-01)

Cystic fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Angela T Nguyen, et al.
Published: (2016-07-01)

Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
by: Helen Gavillet, et al.
Published: (2022-10-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

CD14 C-159T and early infection with <it>Pseudomonas aeruginosa </it>in children with cystic fibrosis
by: Sly PD, et al.
Published: (2005-06-01)

Cutaneous bacteriological profile in patients with pemphigus
by: K C Kiran, et al.
Published: (2018-01-01)

Interspecies interactions induce exploratory motility in Pseudomonas aeruginosa
by: Dominique H Limoli, et al.
Published: (2019-11-01)

A <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Antimicrobial Affects the Biogeography but Not Fitness of <named-content content-type="genus-species">Staphylococcus aureus</named-content> during Coculture
by: Juan P. Barraza, et al.
Published: (2021-04-01)

Bacterial Subversion of Autophagy in Cystic Fibrosis
by: Verónica Roxana Flores-Vega, et al.
Published: (2021-10-01)

<italic toggle="yes">Pseudomonas aeruginosa</italic> Alters <italic toggle="yes">Staphylococcus aureus</italic> Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection
by: Giulia Orazi, et al.
Published: (2017-09-01)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
by: Sheemal Shanista Kumar, et al.
Published: (2019-05-01)

Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran
by: Hossein Fazeli, et al.
Published: (2013-01-01)

Bacterial Profile and Antimicrobial Susceptibility Pattern of Chronic Suppurative Otitis Media from a Tertiary Care Hospital in Kannauj, Uttar Pradesh, India
by: KIRAN YADAV, et al.
Published: (2021-04-01)

Determinação da resistência antimicrobiana associada em isolados clínicos de Staphylococcus aureus e Pseudomonas aeruginosa em um hospital público de Goiânia, Estado de Goiás Determination of associated antimicrobial resistance in clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa in a public hospital in Goiânia, State of Goiás
by: Cláudia Castelo Branco Artiaga Kobayashi, et al.
Published: (2009-08-01)

Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis
by: Helio S. Sader, et al.
Published: (2021-06-01)

Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis
by: Jeffrey M. Flynn, et al.
Published: (2020-04-01)

Does NETosis contribute to the bacterial pathoadaptation in Cystic Fibrosis?
by: Samir eRahman, et al.
Published: (2014-08-01)

High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in Pseudomonas aeruginosa populations sourced from cystic fibrosis lung infections
by: Madeline Mei, et al.
Published: (2023-12-01)